System-generated · Agent desk · Rotation · stock · inception 2026-07-04
Started with ₹10,00,000 · max 10% per position (10 slots).
An agent-run trading desk over Atlas’s ranks (forward-only).
This rulebook was chosen by the system’s walk-forward search, not hand-written — the exact filters above are what won on out-of-sample data. See the Learning log below for how it got here and what it rejected.
Thick bar = this portfolio · thin bar = NIFTY 500 sector weight.
| Instrument | Sector | Qty | Avg cost | Last | Value | Weight | P&L | Comp | Tech | Flow | Val | RS 3M | EMA 50/200 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IPCALAB IPCA Laboratories Limited | Pharma | 58 | 1719.40 | 1770.40 | ₹1,02,683 | 10.3% | +3.0% | 96 | 100 | 58 | 17 | +18.3% | ✓/✓ |
| NUVAMA Nuvama Wealth Management Limited | Capital Markets | 53 | 1887.50 | 1934.60 | ₹1,02,534 | 10.3% | +2.5% | 95 | 100 | 50 | 17 | +44.8% | ✓/✓ |
| RAINBOW Rainbow Childrens Medicare Limited | Healthcare | 69 | 1440.00 | 1481.50 | ₹1,02,224 | 10.3% | +2.9% | 95 | 100 | 50 | 16 | +15.3% | ✓/✓ |
| ZYDUSLIFE Zydus Lifesciences Limited | Pharma | 85 | 1159.00 | 1159.00 | ₹98,515 | 9.9% | 0.0% | 96 | 100 | 60 | 34 | +23.3% | ✓/✓ |
| MEDANTA Global Health Limited | Healthcare | 73 | 1351.10 | 1348.30 | ₹98,426 | 9.9% | -0.2% | 91 | 95 | 58 | 9 | +23.2% | ✓/✓ |
| NEULANDLAB Neuland Laboratories Limited | Healthcare | 5 | 18944.00 | 19542.00 | ₹97,710 | 9.8% | +3.2% | 97 | 100 | 68 | 8 | +27.4% | ✓/✓ |
| AJANTPHARM Ajanta Pharma Limited | Pharma | 29 | 3345.30 | 3307.60 | ₹95,920 | 9.6% | -1.1% | 86 | 90 | 50 | 14 | +14.6% | ✓/✓ |
Lessons earned from outcomes (confidence-weighted, weekly reflection)
50% Reject add‑on trades for any stock that shows a 5‑day decline exceeding 2% after a sector‑wide weakness signal [basis: KIMS was correctly rejected (‑2.88% 5‑day) while a similar negative move would likely hurt performance]
50% Buy pharma stocks that post‑turn exhibit a 5‑day price gain greater than 2% after a sector‑wide pullback [basis: IPCALAB (buy) +2.97% and NEULANDLAB (rejected) +2.92% 5‑day moves after the early pharma turn indicate strong short‑term upside]
| Date | Instrument | Side | Qty | Price | Value | Cost | Realized P&L | Days | Bucket | Tax | Reason |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | ZYDUSLIFE | buy | 85 | 1159.00 | ₹98,515 | ₹116.25 | — | — | — | — | manual |
| 2026-07-09 | MOTILALOFS | sell | 103 | 909.60 | ₹93,689 | ₹96.50 | ₹-6,265 | 3 | stcg | ₹0.00 | manual |
| 2026-07-08 | PTCIL | sell | 5 | 17409.00 | ₹87,045 | ₹89.66 | ₹-2,285 | 1 | stcg | ₹0.00 | manual |
| 2026-07-08 | HBLENGINE | sell | 122 | 781.90 | ₹95,392 | ₹98.25 | ₹-4,492 | 2 | stcg | ₹0.00 | manual |
| 2026-07-07 | PTCIL | buy | 5 | 17827.00 | ₹89,135 | ₹105.18 | — | — | — | — | manual |
| 2026-07-07 | MEDANTA | buy | 73 | 1351.10 | ₹98,630 | ₹116.38 | — | — | — | — | manual |